Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Mohammed S. Elboni"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Thumbnail Image
    Item
    Seroprevalance of Hepatitis E virus among HIV-1 infected patients in Khartoum
    (Al Neelain University-Faculty of Medical Laboratory Sciences, 2016-02) Tayseer A Moneim; Mustafa E Yassin; Abbas B Rahama; Mohammed S. Elboni
    Background: Hepatitis E virus (HEV) is an enterically transmitted pathogen that causes wide scale epidemics of acute hepatitis in highly HEV-endemic areas such as Africa, Asia and the Middle East. HEV can cause chronic infection and cirrhosis in the immunosuppressed, including patients with HIV-1 infection. Little is known about HEV and HIV-1 co infection in Sudan. Objectives: The aim of this study was to detect seroprevalence of HEV antibodies (IgG and IgM) among HIV-1 infected patients in Khartoum, Sudan. Materials and methods: This was descriptive and cross-sectional study, a total of 92 HIV-1 infected patients were tested for anti-HEV IgM and IgG by, using enzyme linked immunosorbant assay (ELISA), in period from December 2015 to March 2016. Result: Out of 92 HIV-1 infected patients, anti-HEV IgG and IgM were detected in 21.7% and 8.7% respectively. HIV-1 infected patients complaining of liver cirrhosis and jaundice were 5 (5.43%) and 46 (50%) respectively. The prevalence of anti-HEV IgG and IgM were 100% and 60% within patient with liver cirrhosis, and 32.6% and 10.9% within patients with jaundice. Conclusions: Regarding IgG, the overall seroprevalence of HEV among study group was high (21.73%), and interestingly it was higher within patients with liver cirrhosis and jaundice.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify